[128] Against this, other DAT inhibitors like bupropion haven't been noticed to exhibit this outcome.[129] These observations have prompted the hypothesis that methylphenidate may possibly work as a "DAT inverse agonist" or "unfavorable allosteric modifier of the DAT" by reversing the path on the dopamine efflux because of the DAT at increased dosa… Read More